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The US Anti-Prostitution Pledge: 
A Call for Cooperation
Jay Silverman, Michele Decker
Masenior and Beyrer’s article is an important contribution 
to the continuing debate as to the direction of public health 
efforts regarding commercial sex work [1]. The authors are 
correct in that the debate between those focused on the 
social and economic rights of prostituted women and girls 
as “workers” and those focused on preventing the trafﬁcking 
of women and girls into prostitution has resulted in precious 
little dialogue on how to best proceed. 
Regrettably, as illustrated by the authors, the US anti-
prostitution pledge may well have contributed to the 
polarization of these two groups. However, to make progress, 
multiple realities must be acknowledged and considered. 
The authors present the conﬂation of sex trafﬁcking and 
prostitution as a barrier to effective action and policy that 
must be eliminated; however, compelling evidence exists to 
support such conﬂation. 
Speciﬁcally, approximately half of sex workers are 
prostituted as minors [2,3]. Studies including prostituted 
minors indicate that virtually all were trafﬁcked into 
sex work [4], and studies of sex workers across multiple 
countries indicate that the majority would prefer to leave 
prostitution if it were safe and economically feasible to do 
so [2,5]. Thus, anti-trafﬁcking advocates may reasonably 
contend that maintaining the institution of sex work through 
decriminalization and organization of health and social 
welfare programs will likely lead to continued trafﬁcking of 
women and girls to maintain this highly proﬁtable activity. 
On the other hand, as presented by Masenior and 
Beyrer, the many thousands of women and girls involved in 
commercial sex work need and deserve assistance based on 
the tremendous health risks they suffer (e.g., HIV infection). 
However, those focused on promoting the health of sex 
workers have often inadequately considered the presence of 
minor girls [6] or trafﬁcking victims in the sex work venues 
within which they operate [7]. While such programs appear 
to empower adults purporting to be engaged in voluntary sex 
work, no evidence suggests that these efforts contribute to 
reducing the numbers or protecting the health of trafﬁcked 
women and girls. 
While we cannot reasonably make the assumption that 
all sex workers are trafﬁcked, we also cannot reasonably 
accept that all sex workers are voluntarily prostituted. 
Amazingly, we have yet to conduct adequate research to 
answer this question. Thus the conﬂation of sex work and 
trafﬁcking continues, as lamented by the authors. To move 
forward, both sides must work together based on their 
common goal of improving the health and well-being of 
this highly vulnerable population. Advocates, practitioners, 
and researchers representing both sides of this debate must 
dialogue to ﬁnd effective means of reducing trafﬁcking of 
women and girls for sexual exploitation, and also to ﬁnd ways 
to assist sex workers to minimize the health risks they face, 
while simultaneously remaining vigilant in detecting and 
humanely assisting prostituted children and adult trafﬁcking 
victims.  
Jay Silverman (jsilverm@hsph.harvard.edu)
Michele R. Decker
Harvard School of Public Health
Boston, Massachusetts, United States of America
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The US Anti-Prostitution Pledge: Authors’ Reply
We would like to thank Jay Silverman and Michele Decker 
for their thoughtful contribution to the public health 
discussion regarding commercial sex work and the grave 
issues of child prostitution and sex trafﬁcking [1]. As the 
correspondents rightly assert, trafﬁcking in persons is a 
criminal and human rights offense and should be vigorously 
opposed and its victims provided services. This is not a 
domain of any real contention in the public health or human 
rights communities. Nevertheless, the conﬂation of all forms 
of sex work with human trafﬁcking, which they contend 
is an outcome of the essential inseparability of these two 
phenomena, does remain contentious. And, as with our 
paper, their work does not, arguably, resolve this contention. 
For the population of consenting adults who sell sex of their 
own volition, in settings as divergent from the India–Nepal 
context where Silverman et al. have worked as Washington 
D. C. or Amsterdam, sex workers and their advocates claim a 
domain of prevention and engagement that also uses human 
rights language, albeit the language of workers’ rights and 
empowerment, to argue for services. And there is ample 
evidence to suggest that empowerment and an end to police 
harassment can improve health outcomes, including HIV.
It may be that the most important issues in sex work and 
sex trafﬁcking are contextual. In Silverman and Decker’s 
recent work, funded by the Ofﬁce to Monitor and Combat 
Trafﬁcking in Persons of the Bush Administration’s 
Department of State, they reviewed medical documentation 
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and case record materials for 287 sex-trafﬁcked and 
repatriated Nepalese girls and women who received services 
at Maiti Nepal between January 1997 and December 2005. 
Their ﬁndings revealed that 109 (38.0%) women and girls 
were HIV positive [2]. In our own work, perhaps 60% of 
ethnic Shan women living in Burma who were trafﬁcked 
to Thailand may be HIV infected [3]. In both these Asian 
communities, the contexts of poverty (Nepal and Burma 
relative to India and Thailand, respectively) and the very 
low status both of women and girls and illegal aliens more 
generally, makes it almost impossible for any sex work not to 
be profoundly exploitative.
In contrast, our work with AIDS service organizations 
in Moscow, Russia has taken place in a markedly different 
context [4]. The majority of women we encountered were 
adults when entering sex work, and over 80% indicated 
willingly entering into sex work and even coming to Moscow 
seeking such work. High rates of unemployment among 
women in the former Soviet Union, due to economic 
depression and gender discrimination, have brought these 
women to the Moscow sex trade seeking income. These 
economic factors are compounded by the fact that the 
majority of women in our sample were ﬁnancially assisting 
or fully supporting family members. The fact that people 
besides themselves were dependent on the income of many 
of the sex workers must be taken into consideration in 
programs aimed at cessation of sex work. But none of the 
women interviewed were Moscow residents before entering 
the Moscow sex industry. Lack of legal status is perhaps 
the largest barrier preventing sex workers from receiving 
many important services and social beneﬁts such as free and 
anonymous medical treatment, a steady job (outside of sex 
work), protection from the police, lodging, and psychological 
assistance. This is not a function of the legality of prostitution 
(sex work is not illegal in the Russian Federation), but of not 
having legal residency.
This example illustrates the highly contextual nature of 
sex work, and indeed, of trafﬁcking, and perhaps argues 
against a “one size ﬁts all” approach to these difﬁcult 
problems.  
Chris Beyrer
Nicole Masenior (nfranck@jhsph.edu)
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, United States of America
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Tobacco Substitutes: Snus and 
Harm Reduction
Maia Szalavitz
How can you even have a debate over whether to publish 
data on snus [1]? No medical journal even contemplated not 
publishing data on needle exchange to prevent HIV—which 
continues addiction just as surely as snus does, while similarly 
producing a dramatic reduction in the risk of death. Journals 
don’t censor data on nicotine replacement or methadone 
maintenance or buprenorphine or even heroin maintenance, 
which continue physical dependence if not always addiction. 
They even publish data on amphetamine maintenance!
What kind of bizarre political correctness would even 
suggest not publishing data that could show whether snus 
improves or harms health? You may want to debate whether 
or not tobacco should be advertised, whether or not the 
industry should be banned and replaced by government 
control of nicotine delivery-devices, even whether tobacco 
should be prohibited entirely. But not publish data on what 
appears to be from existing data an amazingly successful 
public health intervention? What kind of a “public library of 
science” would even contemplate that?  
Maia Szalavitz (maiasz@gmail.com)
Statistical Assessment Service 
New York, New York, United States of America
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Should the Health Community 
Promote Smokeless Tobacco (Snus): 
Comments from British 
American Tobacco
Justine Williamson, Christopher Proctor
Chapman and Freeman question the tobacco industry’s aims 
on snus, and whether these aims can be consistent with harm 
reduction [1]. We cannot speak on behalf of the industry as a 
whole. However, we at British American Tobacco understand 
that cigarette smoking is a major cause of serious and fatal 
diseases, and we believe that the use of Swedish-style snus 
products, while not harmless, is substantially less harmful 
than cigarette smoking [2]. We are piloting snus in several 
countries outside of Sweden as a response to those public 
health stakeholders who have told us they believe that snus, 
properly regulated, can contribute to reducing the net public 
health impact of tobacco use. 
We believe adult consumers of tobacco products would 
beneﬁt from the enactment of a regulatory framework 
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that facilitates consistent, accurate, and meaningful 
communications on the relative health risks of smoking, 
using snus, or abstaining entirely from tobacco use. While 
ideally this framework would be developed and agreed upon 
under the Framework Convention for Tobacco Control, the 
recent second Conference of the Parties to the Framework 
Convention did not address oral tobacco products and has 
not assigned a high priority to tobacco product regulation in 
this area. Given this, we think national governments should 
develop a regulatory framework for snus. In doing so, we 
think that governments should be mindful of the concerns 
expressed by Chapman and Freeman. 
We agree with the recently released preliminary report 
from the European Union’s Scientiﬁc Committee on 
Emerging and Newly Identiﬁed Health Risks, which states 
that “the balance of these effects [beneﬁcial versus adverse 
effects on smoking prevalence] will be highly dependent 
upon the marketing of the product, the health messages 
delivered with it, and the extent to which switching to 
smokeless tobacco products as a harm reduction strategy is 
endorsed by health professionals and their organisations” [3].
We acknowledge that some have concerns with regard to 
our interest in snus as a less harmful alternative to cigarettes. 
We seek to work with the public health community and 
regulators to achieve a reduction in the public health impact 
of tobacco use.  
Justine Williamson (justine_williamson@bat.com)
Christopher Proctor
British American Tobacco
London, United Kingdom
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Should the Health Community Promote Smokeless 
Tobacco (Snus): Author’s Reply
As someone who has researched and advocated for harm 
reduction in the HIV/AIDS [1] and narcotics areas [2], I am 
highly supportive of the general principle of reducing harm 
in public health. My recently released book [3] features a 
29,000 word chapter examining the application of the term in 
tobacco control. My current position is that there is an overly 
seductive simplicity in drawing neat analogies with other areas 
of harm reduction when it comes to tobacco. It is obvious 
that there is immediate beneﬁt to health and society from 
encouraging condom use and clean needle use. However, 
the putative beneﬁts of population experiments with harm 
reduction will not be assessable for 30–40 years.
Behind most calls for harm reduction in tobacco control 
policy lie under-examined assumptions that there is a large 
intractable smoking population for whom cessation is “an 
impossible goal,” as Maggie Brown puts it [4]. In New 
South Wales, Australia where I live, only 13.9% of people 
aged 14 and over now smoke daily. In recent years smoking 
prevalence has been falling faster than at any time in the past. 
There is poor evidence for the “hardening” hypothesis, with 
29% of smokers now describing themselves as only occasional 
smokers and daily consumption falling [5], facts incompatible 
with hardening. Around 75% of smokers say they wish to quit, 
and only about 3.5% of smokers say they want to continue 
using tobacco. It is a fraction of this group that harm 
reduction advocates seek to interest.
While a case may exist for carefully controlled access to 
snus by such a relatively small group, the case for allowing 
the foxes in the tobacco industry into the chicken coop of 
open sales and marketing should alarm anyone with their 
eyes open to the industry’s bottom line. Recent insights 
conﬁrm our caution that Big Tobacco sees snus as a way 
of arresting declines in smoking by promoting dual use. 
Citigroup, the investment advisors, are very clear on the way 
snus will be marketed and used, writing “Over 60% of our 
survey respondents [in the tobacco trade] do not believe 
snus products will have an impact on cig volumes. The trade 
believes that snus will be consumed in addition to cigarettes. 
Given the increased bans on smoking, snus products seem 
like an obvious substitution” [6]. This was echoed in the 
US retail trade newsletter Brandweek: “There’s money to 
be made from municipal smoking bans as another cigarette 
maker chases after smokers who get their nicotine ﬁx between 
their cheek and gum during those many moments when they 
can’t light up” [7].
I’m certain that your British American Tobacco 
correspondents [8] “understand” that cigarettes cause 
disease, as they put it. That being the case, might we 
anticipate British American Tobacco planning to end sales of 
its cigarettes in the areas in which it is test marketing same-
name brand snus? Does it plan to run aggressive, effective, 
graphic advertising campaigns on the dangers of smoking its 
cigarettes?  
Simon Chapman (simonchapman@health.usyd.edu.au)
University of Sydney
Sydney, New South Wales, Australia
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